On December 2, 2025, BioCardia, Inc. appointed Marvin Slosman to its Board of Directors and accepted the resignation of Dr. Richard Krasno, who completed his term without disagreement. The appointment is seen positively as it brings new expertise to the board and was approved during the company's annual meeting where 55.72% of shares were represented.